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Studies in molecular and genetic epidemiology require ahigh-throughput, low cost, and reliable
means of genomic DNA collection. Buccal (cheek) swabs have been proposed as a means of
achieving these goals, but there is little information about the practical application of this
approach. From January 1995 to December 1997, we processed 995 buccal swabs for use in
polymerase chain reaction (PCR)-based genotype assays in the contextofongoing molecular epi-
demiologic studies. Sixhundredforty-seven ofthese swabs wereprocessed ately after col-
lection and 348 were receivedbymail. Wewereable to obtain at least onegenotype from 99.7%
(645 of647) offresh-processed and 97.4% (330 of339) ofmailed biosamples. A PCR success
rate of90.3% (2,546genotypes from 2,819 assays) was achieved. Genotypeswereobtained from
96.1% (1,865 genotypes from 1,941 assays) of fresh-processed biosamples and 77.6% (681
genotypes from 878 assays) ofmailed biosamples. PCR success rates at any single locus ranged
from 92.6 to 98.8% (fresh-processed) and 75.5 to 79.6% (mailed). The PCRsuccess rate among
fresh-processed biosamples was significantly higher than among mailed biosamples (Fisher's
exact test p < 0.0001), and more attempts were required to obtain a successfil PCR result for
mailed biosamples as comparedto fresh-processed biosamples. Forone locus (CYP3A4), asubset
ofmailed biosamples was purified iftwo or more PCR failures occurred. Additional genotypes
were obtained in 58.3% ofthese previouslyfailed biosamples. Time from biosample receipt to
DNAetaction had no effect on PCRsuccess. After storage ofprocessed biosamples for as long
as 3 years, there was no appreciable decrease in the rate ofPCR success. These results suggest
that adequate DNA for PCR-based applications can be obtained from buccal swabs, but sam-
pling or processing considerations may be important in obtaining optimal results. Key word
biosample, genetic epidemiology, molecular epidemiology, polymerase chain reaction. Environ
HealthPerpect 107:517-520 (1999). [Online 12 May 1999]
hbp://ehpntl.niehs.nih.govldoeasl)999/07p517-520wa&rlabstract.htmi
Numerous methods are available for the col-
lection ofgenomic DNA for use in molecu-
lar epidemiologic and other studies that
require high-throughput, reliable biosam-
pling methods. These methods include the
collection ofperipheral blood by venipunc-
ture or on blood spot (Guthrie) cards (1);
hair roots (2); urine (3-6); mouth washes
(4); andwood, brush, or cotton buccal swabs
(8-13). Each approach has distinct advan-
tages and disadvantages. Venipuncture col-
lection of peripheral blood is the most
expensive and most difficult approach to
process. It is also invasive and confers the
most discomfort to study subjects and the
greatest risk of infection to laboratory per-
sonnel. However, it also provides the materi-
al required for protocols such as Southern
blotting or initiation ofcell lines. In contrast,
other available methods are less invasive and
less costly, but mayprovide smaller or incon-
sistent quantities ofDNA. These approaches
may be appropriate for some molecular epi-
demiologic applications in which high-
throughput processing capability is required.
In the present study, we evaluated the use of
buccal swab biosampling to obtain genomic
DNA for use in polymerase chain reaction
(PCR)-based genotyping assays.
Materials and Methods
Sample subjects and biosample collection.
Biosamples were obtained from 995 study
subjects between January 1995 and
December 1997. Study subjects were par-
ticipants in molecular epidemiologic stud-
ies ofprostate cancer and melanoma at the
Hospital ofthe University ofPennsylvania
(HUP). These subjects included 447 cases
ofprostate cancer, 166 cases ofmelanoma,
and 382 controls. These subjects ranged in
age from 40 to 96 years (mean, 62.7 years).
All subjects were contacted through out-
patient clinics at HUP, and provided
informed consent under institutional
review board-approved protocols. These
biosamples were collected from buccal
swab (cytological) brushes (Cyto-Pak
Cytosoft Brush, Camarillo, CA), which
were provided to each subject in sealed,
sterile plastic tubes. Subjects were given the
choice to collect the swab at the time of
their clinic visit or take the swab with them
to be collected and mailed back at a later
date. All subjects were provided with an
instruction card to which the buccal swabs
were attached. The card guided the sub-
jects to remove the swab from the sterile
tube and rub the brush on the inside ofthe
mouth for 15-30 sec. The subjects were
then instructed to replace the swab in the
tube and either return it immediately to
study staffor mail it back using an attached
stamped envelope. Six hundred forty-seven
(65%) subjects agreed to participate imme-
diately by self-collecting and returning a
buccal swab biosample at the time of their
clinic visit. The remaining 348 (35%) sub-
jects chose to self-collect the buccal swab
biosample after the time oftheir clinic visit,
or were contacted for participation by mail
after the time oftheir clinic visit. The latter
group ofsubjects returned the swabs to the
laboratory by U.S. mail.
Although it was outside the scope ofthe
present study to evaluate the acceptability
ofbuccal swab sampling overall or in com-
parison with venous blood sampling, we
achieved a 95% participation rate pverall
among study subjects who agreed to partici-
pate in our studies to date (data not
shown), with 85-90% participation among
those who mailed back buccal swabs and
nearly 100% among those fresh-processed.
When recontacted, many of those subjects
who did not return the mailed buccal swabs
cited having been very busy or having for-
gotten to return the swab. Although not
based on systematic data collection, these
anecdotal results suggest that the level of
acceptance of buccal swabs for biosample
collection may be high.
Biosample processing. Upon receipt in
the laboratory, all swabs were placed at 40C
until DNA extraction. Genomic DNA
extraction was undertaken using a protocol
modified from Richards et al. (11). Upon
receipt in the laboratory and after removal
ofthe swab handle, the brush section ofthe
swab was placed inside a 1.5-mL microcen-
trifuge tube, and 600 pL of50 mM NaOH
was added. The tube containing the brush
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was closed and then vortexed for 10 min.
The tube was then heated at 95°C for 10
min. Finally, 120 pL 1 M Tris (pH 8.0) was
added to the tube, after which the brush was
removed and discarded. The resulting
biosample solution containing genomic
DNA was stored at 4°C. Between 5 and 10
pL of this biosample is used in a typical
PCR reaction, suggesting that the 720 piL
biosample should provide sufficient genom-
ic DNA for 72-144 PCR reactions. A ran-
domly chosen subset ofbuccal swab biosam-
ples was purified ifthe sample produced two
or more failed PCR assays at CYP3A4
(whether or not they failed in any other
assay). Purification was undertaken using
the Puregene DNA Isolation Kit D5000A
(Gentra Systems, Inc., Minneapolis, MN)
according to the manufacturer's recom-
mended protocol. All processed biosamples
were stored at 40C from time of DNA
extraction until PCR analysis.
PCRgenotype analysis. The protocol of
Rebbeck et al. (14) was used to amplify a
592-bp fragment upstream from CYP3A4.
Amplification products were visualized by
conformation-sensitive gel electrophoresis
ofthe PCR product on a 10% nondenatur-
ing polyacrylamide gel after staining with
ethidium bromide. CYP3A4 genotyping
was not undertaken on melanoma cases.
Glutathione-S-transferase p (G,STM])
genotypes were generated using a protocol
modified from Davies et al. (15). The
primers amplifying GSTMI were 5' CTG
CCC TAC TTG ATT GAT GGG 3' and
5' CTG GAT TGT AGC AGA TCA TGC
3'. As a positive internal control, a portion
of the P-globin gene was amplified simulta-
neously with GSTM1 using the primers of
Saiki et al. (16). The PCR reagent mix con-
sisted of5 pL 10 x reaction buffer [100 mM
Tris-HCl (pH 9.0), 500 mM KCI, 10% (v/v)
Triton, 15 mM MgCl2I, 1 pL 1OmM
dNTPs, 5 pL each 5-,uM primers, 10 pL
buccal swab DNA, 14.5 pL dd H20, and
0.5 ,uL AmpliTaq (Perkin Elmer, Norwalk,
CT), for a total volume of 51 pL. The tem-
perature cycling protocol was one cycle of
940C for 3 min, 820C for 1 min, then 30
cycles of 940C for 1 min, 55°C for 1 min,
and 720 for 2 min, followed by one cycle for
10 min at 720C. Glutathione-S-transferase 0
(GSTTI) genotypes were generated using
the primers of Pemble et al. (17). As with
GSTM], simultaneous amplification of the
P-globin gene (16) was used as a positive
internal control. The PCR reaction mixture
consisted of 0.25 pL 10 mg/mL bovine
serum albumin, 2.5 pL 10 x PE buffer II
(Perkin Elmer), 1 pL 25 mM MgCl, 0.5 pL
10 mM dNTPs, 2.5 pL of each 5-pM
primers, 6 pL buccal swab DNA, 4.45 pL
dd H,O, and 0.3 pL AmpliTaq, for a total
volume of 25 pL. The temperature profile
for the PCR reaction was 93°C for 2.3 min,
82°C for 1 min, 35 cycles of 93°C for l
min, 58C for 1 min, and 72°C for 1 min,
followed by a cycle of93°C for 30 sec, 58°C
for I min, and 720C for 7.5 min. For both
GSTM] and GSTT], visualization took
place on a 2% agarose gel after staining with
ethidium bromide. PCR success was defined
as any scorable genotype result. GSTM] or
CSTT1 genotypes were not considered valid
unless a successful 3-globin amplification
product was observed.
Statistical methods. Comparisons of
proportions in contingency tables used
Fisher's exact tests (FET). Kruskal-Wallis
X statistics were used for analysis of con-
tinuous variables. All reported p-values
were based on two-sided tests.
Results and Discussion
Effect offresh-processed versus mailed
biosampling. Table 1 presents a comparison
of PCR-based genotype results on mailed
and fresh-processed buccal swabs. PCR fail-
ure occurred at all three test loci in only 12
of 995 subjects. Thus, we estimated a
98.8% PCR success rate overall, with a suc-
cess rate of 99.7% in fresh-processed and
97.4% in mailed biosamples. Of the 2,819
assays undertaken at three loci, successes
were observed in 2,546 (90.3%) assays. Of
the 1,941 genotype assays undertaken in
fresh-processed biosamples, PCR successes
were observed in 1,865 (96.1%) assays.
These estimates are consistent with those
reported by Richards et al. (11), who
reported a PCR success rate of95 and 99%
at the CFTR gene after collecting one and
two buccal swabs, respectively. In contrast,
PCR success among mailed biosamples
occurred in 681 of878 (77.6%) assays. The
success rate in fresh-processed biosamples
was significantly higher than that in mailed
biosamples (FET p-value < 0.0001). As
indicated in Table 1, PCR success rates at
any single locus ranged from 92.6 to 98.8%
for fresh-processed samples and 75.3 to
81.3% for mailed samples. Although not
systematically evaluated, the majority of
those samples on which we obtained PCR
results were achieved on the first attempt.
However, the present study was limited
because we were not able to systematically
quantitate the distribution of repeat assays
required to obtain a PCR success. Despite
this limitation, we conclude that the major-
ity of both fresh-processed and mailed buc-
cal swabs can provide adequate DNA for
PCR analysis. However, fresh-processed
buccal swab biosamples are less likely to
have PCR failures than mailed biosamples
using the protocols described here. Thus,
the higher PCR failure rate among mailed
biosamples could be explained bv decreased
DNA quality or quantity rather than the
total absence ofDNA.
We also observed significant differences
in PCR success rates across loci (Table 1).
Fresh-processed biosample PCR success
rates were significantly different between
CSTM] and GS771 (FET p-value=
0.034), between GSTM] and (CYP3A4
(FET p-value < 0.0001), and between
GSTT] and CYP3A4 (FET- p-value -
0.0003). Mailed biosample PCR success
rates were not significantly different across
loci. Therefore, there mav be substanitial
variation in PCR success rates depending
on the locus or assay used. Although each of
the assays used was optimized for buccal
swab biosamples, it may be useful to con-
sider optimizing PCR conditions depend-
ing on the biosample collection method.
For example, the use of NaOH in DNA
extraction may alter the pH of the PCR
reaction, even though a small quantity of
buccal swab-derived biosample is used.
Thus, optimization ofPC'R conditions con-
sidering pH may be an importanit step in
determining PCR conditions. However, we
were able to achieve high rates of PCR s-ic-
cess after we optimized amplification con-di-
tions for these buccal swab biosamples. Otur
results suggest that the potentially high pH
of our processing/storage solution need not
adversely affect the ability to obtain high
PCR success rates.
Table 1. Comparison of PCR results using fresh-processed and mailed buccal swabs: number of assay
successes/total assays conducted (percent success).a
CYP3A4 GSTM1, GSTT1,
GSTM1 GSTT1 Unpurifiedb purifiedb Total and CYP3A4
Fresh-processed 639/647 627/647 509/511 90/136 599/647 1,865/1,941
(98.8%) (96.9%) (99.6%) (66.2%) (92.6%) (96 1%)
Mailed 271/348 262/348 120/134 28/48 148/182 681/878
(77.9%) (75.3%) (89.6%) (58.3%) (81.3%) (77.6%)
Total 910/995 889/995 629/645 118/184 747/829 2,546/2,819
(91.5%) (89.3%) (97.5%) (64.1%) (90.1%) (90.3%)
Abbreviations: GSTM1, glutathione-S-transferase p; GSTT1, glutathione-S-transferase 0; PCR, polymerase chain reaction.
aln all comparisons of success rates in fresh-processed versus mailed buccal swabs, fresh-processed biosamples had a
significantly higher PCR success rate with a Fisher's exact test p-value < 0.0001. bPurified samples were those that had
failed on initial analysis and were then subjected to a process that removed non-DNA contaminants. Nonpurified samples
were not subjected to this process.
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Finally, multiple attempts were some-
times necessary before a PCR success was
obtained, and the number of repeat
attempts required to achieve PCR success
varied significantly between fresh-processed
and mailed biosamples. We collected infor-
mation about the number of attempts
required to achieve PCR success for 825
CYP3A4 genotypes and 990 GSTMI geno-
types. For CYP3A4, 616 (74.7%) PCR reac-
tions were successful on the first attempt,
whereas 97 (11.8%) required two attempts,
67 (8.1%) required three attempts, and 45
(5.5%) required four or more attempts. The
mean number of PCR attempts before a
success at CYP3A4was 1.3 [standard devia-
tion (SD) = 0.8] for fresh-processed biosam-
ples and 1.8 (SD = 1.3) for mailed biosam-
ples [Kruskal-Wallis x2 = 16.49, degrees of
freedom (dfl = 1, p-value < 0.0001). For
GSTM1, 655 (66.2%) PCR reactions were
successful on the first attempt, 102 (10.3%)
required two attempts, 137 (13.8%)
required three attempts, and 96 (9.7%)
required four or more attempts. The mean
number ofPCR attempts before a success at
GSTMJ was 1.5 (SD = 1.0) for fresh-
processed biosamples and 2.1 (SD = 1.3) for
mailed biosamples (Kruskal-Wallis X2 =
82.40, df= 1, p-value < 0.0001). Therefore,
the majority ofbiosamples provided a suc-
cessful PCR result after a single attempt, but
the number ofattempts required to achieve
PCR success was significantly higher in
mailed biosamples as compared to fresh-
processed biosamples.
Our data do not allow us to directly
infer why PCR failures were more common
among mailed biosamples. One explanation
for the observed differences is incorrect
biosample collection by subjects, who did
not collect the biosamples in the presence of
study staff. It is plausible that some mailed
swabs contained insufficient material
because ofshorter or less vigorous swabbing
than might have occurred in the clinic.
Buccal swabs were accompanied by an
instruction card that described the proper
swabbing procedure. However, there was no
way to evaluate whether the subjects
adhered to the recommended collection
method. The vigorous processing that
included extreme temperature and pH con-
ditions minimized the possibility ofbacterial
contamination ofthe samples. This was sup-
ported by the lack of apparent bacterial
growth in any biosample. Another explana-
tion for increased mailed biosample failures
includes exposure to extremes in tempera-
ture or drying out ofthe swabs prior to their
arrival at the laboratory. Upon receipt, we
observed a small number of damaged (e.g.,
cracked or shattered) tubes that may have
dried out prior to processing. However,
there was no higher failure rate among these
samples that could explain a significant pro-
portion of mailed biosample PCR failures
(results not shown).
Biosample storage conditions prior to
laboratory receipt could have contributed
to DNA degradation or otherwise result in
poor biosample quality. Meulenbelt et al.
(12) suggested that cotton swabs kept dry
for 7 or more days after collection and
before processing resulted in decreased
DNA yields. Freeman et al. (13) evaluated
the use of a buffered storage/preservative
solution (STE buffer: 100 mM NaCl, 10
mM Tris-HCL at pH 8, 10 mM EDTA at
pH 8, 0.2 mg/mL proteinase K, and 0.5%
SDS) for use in mailed buccal swab
biosampling protocols. This protocol used
three biosample collections per subject at
various times in a day, using a total of 10
cotton swabs stored for mailing in STE
buffer. At least one PCR-based genotype
was obtained from all adult biosamples.
Although these conditions may be optimal
for mailed buccal swab protocols, the
requirement ofmultiple swabbings may be
a limiting factor for some studies. As a par-
tial solution, we now request at least two
buccal swabs from each study subject to
increase the chances ofobtaining sufficient
DNA for PCRapplications.
Effect of biosample purification.
We evaluated whether the purification of
buccal swab biosamples could provide addi-
tional PCR success for biosamples in which
PCR failures occurred at CYP3A4.
Presumably, purification increases DNA
concentration and removes impurities (e.g.,
proteins and cell residue). A random subset
of biosamples was purified because the
biosamples previously failed in more than
one CYP3A4 assay. It was not surprising
that the CYP3A4failure rate remained high
even after purification (Table 1). However,
additional CYP3A4 genotype data were
obtained from 58.3% of all purified
biosamples, which increased the PCR suc-
cess rate from 65.9% (120 PCR successes of
182 biosamples prior to purification) to
81.3% for CYP3A4 overall. Furthermore,
PCRfailures were not significantly different
between purified fresh-processed and puri-
fied mailed buccal swab biosamples (FETp-
value = 0.382). These results suggest that
purification of mailed biosamples may
improve PCRsuccess.
Effectoftimefrom laboratory receiptto
DNA extraction. The mean time from lab-
oratory receipt to DNA extraction (i.e.,
preprocessing storage time at 4°C) was 1.0
day overall (range, 0-9 days). Fresh-
processed buccal swabs had a longer mean
delay until processing than mailed buccal
swabs (1.1 vs. 0.8 days; Kruskal-Wallis X21
= 35.33, P-value < 0.0001), with 75.3% of
fresh-processed and 83.3% of mailed buc-
cal swabs processed within 1 day oflabora-
tory receipt. Therefore, higher failure rates
among mailed biosamples cannot be
explained by longer delays from laboratory
receipt until processing. There was also no
clear trend toward higher CYP3A4 PCR
failure rates with longer delays between
biosample receipt and processing (Table 2).
For example, biosamples stored for 4 days
or more before processing did not have sig-
nificantly higher failure rates than those
processed immediately upon receipt in the
laboratory (FET p-value = 0.215 for fresh-
processed and 0.198 for mailed biosam-
ples). Therefore, it does not appear that
immediate biosample processing is neces-
sary to achieve good PCR results. Our
experience is consistent with that reported
by Richards et al. (11), who evaluated PCR
success after storage of swabs at 40C prior
to processing for periods of3 days, 1 week,
2 weeks, 1 month, and 10 months, and
found no significant effect on PCR yield.
These authors also reported no significant
effect on DNA yield from swabs stored
prior to processing in high temperature,
high humidity, or freezing conditions. Our
experience with mailed buccal swabs sug-
gests that uncontrolled storage or collection
conditions prior to laboratory receipt may
affect PCR success. However, we have not
collected data about time from actual swab
collection to receipt in the laboratory for
mailed samples, nor about storage condi-
tions prior to mailing. Therefore, we can-
not evaluate the effect of conditions prior
Table 2. Effectoftime from biosample receiptto processing (i.e., preprocessing storagetime) on polymerase
chain reaction success.
Process No. successes/total biosamples analyzed (% success)a
delay(days) Fresh-processed Mailed Total biosamples
0 236/258(91.5%) 143/223(64.1%) 379/481 (78.8%)
1 203/229(88.6%) 39/67(58.2%) 242/296(81.8%)
2 26/34(76.5%) 11/17 (64.7%) 37/51 (72.5%)
3 73/77 (94.8%) 14/16 (87.5%) 87/93(93.5%)
4 28/33 (84.8%) 3/6(50.0%) 31/39(79.5%)
5-9 13/16 (81.3%) 9/19(47.4%) 22/35(62.9%)
Total 579/647 (89.5%) 219/348(62.9%) 798/995(80.2%)
Includes any failure atglutathione-S-transferase p or glutathione-S-transferase 0.
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to the receipt ofmailed buccal swabs in the
laboratory. Additional follow-up will also
be required to evaluate the effect of long-
term storage on PCR success in buccal
swab biosamples.
Effect oflong-term storage. To evaluate
the effect of long-term biosample storage,
we retrieved 137 fresh-processed biosam-
ples that had been stored for 12-24
months (n = 50), 24-36 months (n = 50),
and more than 36 months (n = 37) at 40C.
The maximum storage time was 41
months. Each ofthese samples was selected
for reanalysis because we had obtained a
successful PCR result at GSTMI and
GSTTI at the time ofthe initial biosample
processing. The GSTMI and GSTT1 assays
were repeated on all 137 samples. A suc-
cessful PCR result was obtained for at least
one locus from all samples. This result sug-
gested that no complete degradation of
DNA occurred following storage at 4°C.
However, of the 274 genotype assays
undertaken (i.e., 137 biosamples assayed
for GSTMI and GSTTJ), 24 PCR failures
at one locus or the other (8.8%) were
observed: 6 of 100 assays (6%) failed in
samples stored 12-24 months, 11 of 100
assays (11%) failed in samples stored
24-36 months, and 7 of 74 assays (9.5%)
failed in samples stored more than 36
months. This did not represent a trend
toward higher failure rates with longer stor-
age times (X2 = 1.63, df= 2, p = 0.443).
Despite the fact that PCR success rates
remained high after storage at 40C for at
least 12 months, these results imply that
PCR success may diminish slightly after
storage relative to genotype results obtained
shortly after biosample collection.
DNA concentration. We estimated
DNA concentration using the DNA
Dipstick Kit (InVitrogen, Inc., Carlsbad,
CA) using DNA biosamples from a random
sample of 43 buccal swabs. As described
below, half of these had immediate PCR
success and the other half had repeated
PCR failures. The mean DNA concentra-
tion overall was 3.7 ng/pL (SD, 3.1; range,
0.3-10.0). Because the total volume ofour
sample was approximately 720 ,uL, we esti-
mated a mean DNA yield of 2.7 pg per
buccal swab. Although this estimate was
based on a small number ofsamples using a
relatively crude quantification method, it
was consistent with the report of Freeman
et al. (13), who used spectrophotometry
and agarose gel comparisons against stan-
dards of known DNA concentrations to
quantitate the amount of DNA obtained
under their 10-swab protocol. They obtained
an average yield of32 pg (range, 3.2-110.8
pg) from 2-year-old children and 38 pg
(range, <1-108 pg) from adults. Taken
together, these results suggest that a single
buccal swab mayyield approximately 3 pg of
genomic DNA. In contrast, peripheral blood
samples typically produce genomic DNA
concentrations in excess of100 pg.
To evaluate whether PCR failure rates
might be explained by differences in DNA
concentration, we compared 21 samples
that failed to produce PCR results for at
least two loci (19 of which never resulted
in a successful PCR amplification), and 22
which had never failed at any locus, with
PCR amplification success at the first try at
every locus. There was no difference in the
DNA concentration between those samples
that failed (mean concentration, 3.6 ng/pL;
SD, 3.0; range, 0.3-10.0 ng/pL) and those
that did not fail (mean concentration, 3.7
ng/pL; SD, 3.2; range, 0.3-10.0 ng/pL;
Kruskal-Wallis x2 = 0.01; df= 1; p-value =
0.930). Although the method used to
quantitate DNA here is relatively crude, we
can conclude that the concentration is sub-
stantially lower than that obtained typically
from DNA extracted from peripheral
blood, but that PCR failures are unlikely to
be explained by differences in DNA con-
centration or yield.
Conclusions
Buccal swabs may be an efficient, relatively
noninvasive means ofobtaining DNA rela-
tive to peripheral blood sampling. Buccal
swab collection protocols are less costly,
less time consuming, less invasive, and pose
lowered risk for both the subject and labo-
ratory personnel. However, our results sug-
gest that fresh-processed buccal swabs pro-
vide a higher PCR success rate than mailed
buccal swabs. Thus, fresh processing of
buccal swabs should be undertaken when
possible. For study designs in which it may
be desirable to use mailed buccal swabs,
steps may need to be taken to optimize
PCR success. We have determined that
biosample purification can improve PCR
successes. However, additional modifica-
tions to the protocols for biosample collec-
tion (e.g., collection ofmultiple swabs and
use ofbuffered storage media), the mailing
process (e.g., use of express mail in sealed
packets to prevent drying), or the PCR
assay conditions could also be considered.
Despite these limitations, buccal swabs can
be useful sources of genomic DNA for
some PCR-based applications.
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